RET

ADC Related

ADC Antibody ADC Cytotoxin ADC Linker ADCs Drug-Linker Conjugates for ADC
Angiogenesis

5-alpha Reductase ALK Bcr-Abl BTK EGFR FAK FLT3 HER-2 HIF Src Syk VDA VEGFR
Anti-infection

Antibiotic Arenavirus Bacterial CMV EBV Enterovirus Filovirus Fungal Gli HBV HCV HCV Protease HIV HSV Influenza Virus Parasite RABV Reverse Transcriptase RSV SARS-CoV TMV Virus Protease
Apoptosis

Apoptosis ASK Bcl-2 Caspase c-Myc c-RET Cytohesin DAPK Ferroptosis FKBP IAP Mdm2 p53 PD-1 PD-L1 PERK PKD Ras RIP kinase ROS Survivin Thymidylate Synthase TNF Receptor TNFa TRADD
Autophagy

Autophagy LRRK2 Mitophagy OGA ULK
Cell Cycle

Antifolate APC Aurora Kinase BMI-1 CDK Chk c-Myc Eukaryotic Initiation Factor G-quadruplex HDAC HSP Kinesin LIMK Mad2 Microtubule(Tubulin) Mps1 Nucleoside Antimetabolite/Analog Nur77 p21 PAK PERK PFKFB PLK PPAR Ras Rho ROCK SRPK TOPK Topoisomerase Wee1
Cytoskeletal Signaling

Arp2 3 Complex Bcr-Abl Cardiac Myosin Dynamin Gap Junction Protein HSP Integrin Kinesin Microtubule Associated MLCK Myosin PAK TACC3 Wntbeta-catenin
DNA Damage

ATM(ATR) CRISPR(Cas9) DNA alkylator DNA Stain DNA(RNA) Synthesis GAK HDAC HSP Nucleoside Antimetabolite(Analog) OGG1 p97 PARG PARP RAD51 RNR Sirtuin SMN Telomerase Topoisomerase
Endocrinology & Hormones

5-alpha Reductase ACE Adrenergic Receptor Androgen Receptor Aromatase Estrogenprogestogen Receptor Glucocorticoid Receptor GPR Mineralocorticoid Receptor RAAS THR TSH Receptor
Epigenetics

AMPK Aurora Kinase DNA Methyltransferase Epigenetic Reader Domain EZH1 2 HDAC HIF Histone Acetyltransferase Histone Demethylase Histone Methyltransferase JAK MAT MicroRNA MLL Pim PKC Protein Arginine Deiminase Sirtuin Small Interfering RNA (siRNA) SMYD

+MORE

RET

RET related products

Cat No.	Product Name	CAS No.	Product Description
V3376	AST487 (NVP- AST487)	630124-46-8	AST487 (also known as NVP- AST487) is a novel and potent inhibitor of RET kinase with anticancer activity.
V4830	Pralsetinib (BLU 667)	2097132-94-8	Pralsetinib (GAVRETO; BLU667; BLU-667) is a novel, highly potent, selective, FDA approved RET inhibitor with anticancer activity.
V118829	RET G810R Recombinant Human Active Protein Kinase		Transfection rearrangement (RET) is a transmembrane receptor protein tyrosine kinase (PTK).
V144043	RET Ligand-Linker Conjugate-1		RET Ligand-Linker Conjugate-1 is a conjugate composed of RET ligands and linkers.
V79251	RET-IN-26		RET-IN-26 (compound D5) is a RET kinase inhibitor (antagonist) with IC50 of 0.33 μM.
V144045	RET-IN-29		RET-IN-29 is a selective RET kinase inhibitor.
V69545	RET-IN-5	2725770-20-5	RET-IN-5 is a potent RET inhibitor (antagonist) with IC50 of 4.57 nM (WO2021213476A1, compound 18).
V147268	YW-N-7 TFA		YW-N-7 TFA is a PROTAC that targets and inhibits the degradation of RET kinase, with a DC50 of 88 nM.
V69535	Zeteletinib hemiadipate (BOS-172738 hemiadipate; DS-5010 hemiadipate)	2375837-06-0	Zeteletinib (BOS-172738; DS-5010) hemiadipate is an orally bioactive, selective RET kinase inhibitor (antagonist) with nanomolar potency for RET and >300-fold selectivity for VEGFR2.
V110742	ZW-6-052		ZW-6-052 (compound 20) is a derivative of ZW-18-116 and is a dual-target PROTAC degrader that can degrade the oncoproteins TRKA and RET.